Oxidative stress in Alzheimer's disease hippocampus: A topographical study

Journal of the Neurological Sciences

Volumn 299, Issue 1-2, 2010, Pages 163-167

  Cruz Sanchez F F ^a   Girones X ^a   Ortega, A ^b   Alameda, F ^a,c   Lafuente, J V ^d  

^a UNIVERSITAT INTERNACIONAL DE CATALUNYA   (Spain)

^b Department of Pathology   (Spain)

^c HOSPITAL DEL MAR   (Spain)

^d UNIVERSITY OF THE BASQUE COUNTRY UPV EHU   (Spain)

Author keywords

Advanced glycation end products; Alzheimer's disease; Brain microcirculation; Hippocampus; Oxidative stress

Indexed keywords

ATAXIN 1; ATAXIN 3;

AGED; ALZHEIMER DISEASE; ARTICLE; BRAIN CORTEX; BRAIN REGION; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GROUPS BY AGE; HIPPOCAMPUS; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; OXIDATIVE STRESS; PRIORITY JOURNAL; TOPOGRAPHY;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; GLYCOSYLATION END PRODUCTS, ADVANCED; HIPPOCAMPUS; HUMANS; IMMUNOHISTOCHEMISTRY; MIDDLE AGED; NEUROFIBRILLARY TANGLES; NEURONS; OXIDATIVE STRESS;

EID: 78649516312     PISSN: 0022510X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jns.2010.08.029     Document Type: Article

References (22)

1. K. Bigl, F. Gaunitz, A. Schmitt, S. Rothemund, R. Schliebs, and G. Münch Cytotoxicity of advanced glycation endproducts in human micro- and astroglial cell lines depends on the degree of protein glycation J Neural Transm 115 11 2008 1545 1556
2. X. Gironès, A. Guimera, C.Z. Cruz-Sánchez, A. Ortega, N. Sasaki, and Z. Makita N-carboxymethyllysine in brain aging, diabetes mellitus and Alzheimer's diseases Free Radical Biol Med 36 10 2004 1241 1247
3. H. Braak, E. Braak, and J. Bohl Staging of Alzheimer-related cortical destruction Eur Neurol 33 6 1993 403 408
4. C. Bouras, J. Constantinidis, and R. Tissot Cicatrices ischemiques bilaterales de l'hippocampe limitées au secteur de Sommer er au subiculum. Etude neuropathologique et correlations anatomo-cliniques Neurology 379 1978 65 81
5. K. Sano, and T. Kirino Ammon's horn sclerosis: its pathogenesis and clinical significance Tohoku J Exp Med 161 1990 273 295 Suppl
6. F. Pasquier, A. Boulogne, D. Leys, and P. Fontaine Diabetes mellitus and dementia Diab Metab 32 5Pt1 2006 403 414
7. N. Sasaki, S. Toki, H. Chowei, T. Saito, N. Nakano, and Y. Hayashi Immunohistochemical distribution of the receptor for advanced glycation end products in neurons and astrocytes in Alzheimer's disease Brain Res 888 2001 256 262
8. M. Takeuchi, Z. Makita, K. Yanagisawa, Y. Kameda, and T. Koike Detection of noncarboxymethyllysine and carboxymethyllysine advanced glycation end products (AGE) in serum of diabetic patients Mol Med 5 1999 393 405
9. T. Sato, N. Shimogaito, X. Wu, S. Kikuchi, S. Yamagishi, and M. Takeuchi Toxic advanced glycation end products (TAGE) theory in Alzheimer's disease Am J Alzheimers Dis Other Demen 21 3 2006 197 208
10. M. Takeuchi, S. Kikuchi, N. Sasaki, T. Suzuki, T. Watai, and M. Iwaki Involvement of advanced glycation end-products (AGEs) in Alzheimer's disease Curr Alzheimer Res 1 1 2004 39 46
11. J.C. De la Torre Impaired cerebrovascular perfusion. Summary of evidences in support of its causality in Alzheimer's disease Z.S. Khachaturian, M.M. Mesulam, Alzheimer's disease. A compendium of current theories Annals of NYAS vol. 924 2000 136 152
12. I. Ushimura Zur pathogenese der örlichelektiven Ammonshornerkrankung Ztschr Neurol Psychiatry 114 1928 567 601
13. H.M. Duvernoy The human hippocampus Functional anatomy, vascularization and serial sections with MRI 3rd ed. 2005 Springer Berlin
14. C. Vogt, and O. Vogt Sit und wesen der krankheiten im lichte der topistischen hirnforschung und des variierens der tiere. I. Teil. Befunde der topistichen hirnforschung als beitrag zur lehre von krankheissitz J Psychol Neurol (Leipzig) 47 1937 241 457
15. J. Cervós-Navarro, and J. Iglesias-Rozas The arteriole as a site of metabolic exchange J. Cervós-Navarro, E. Betz, G. Ebhardt, R. Ferszt, R. Wuellenweber, Advances in neurology Vol.20 1978 Raven Press New York 17 24
16. U. Ueberham, and T. Arendt The expression of cell cycle proteins in neurons and its relevance for Alzheimer's disease Curr Drug Targets CNS Neurol Disord 4 3 2005 293 306
17. T. Arendt Synaptic plasticity and cell cycle activation in neurons are alternative effector pathways: the 'Dr. Jekyll and Mr. Hyde concept' of Alzheimer's disease or the yin and yang of neuroplasticity Prog Neurobiol 71 2-3 2003 83 248
18. G. Münch, J. Gasic-Milenkovic, and T. Arendt Effect of advanced glycation endproducts on cell cycle and their relevance for Alzheimer's disease J Neural Transm Suppl 65 2003 63 71
19. R.N. Auer, J.F. Dunn, and G.R. Sutherland Hipoxia and related conditions S. Love, D.N. Louis, D.W. Ellison, 8th ed. Greenfield's Neuropathology 2008 Hodder Arnold, London 63 119
20. M.A. Pappolla, T.K. Bryant-Thomas, D. Herbert, J. Pacheco, M. Fabra Garcia, and M. Manjon Mild hypercholesterolemia is an early risk factor for the development of Alzheimer amyloid pathology Neurology 61 2 2003 199 205
21. J. Pacheco-Quinto, E.B. Rodriguez de Turco, S. DeRosa, A. Howard, F. Cruz-Sanchez, and K. Sambamurti Hyperhomocysteinemic Alzheimer's mouse model of amyloidosis shows increased brain amyloid beta peptide levels Neurobiol Dis 22 3 2006 651 656
22. H. Gastaut, and H.J. Lammers Anatomie du Rhinencéphale Physiologie et pathologie du Rhinencéphale 1961 Masson et Cie Paris 2 Vols., 166p, 337p, ills., or.pr.wrps